There were 2,421 press releases posted in the last 24 hours and 441,336 in the last 365 days.

Contact

Please use this form to send email to PR contact of this press release:
Inventiva announces the positive recommendation of the fifth DMC of the NATiV3 Phase 3 clinical trial with lanifibranor in patients with MASH

TO:



FROM:

Please check your email address!

Please, do not fill this field.

Please, do not change this field.

Please, do not fill if your javascript is turned off.

captcha image